LFWD (Lifeward) NonCurrent Deferred Revenue: $1.21 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LFWD Lifeward Ltd LFWD
52 GF Score
Price $7.45
GF Value $13.87
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Lifeward NonCurrent Deferred Revenue?

Lifeward LFWD -5.64% 52 NonCurrent Deferred Revenue is $1.21 Mil as of Mar. 2026. GuruFocus rates LFWD with a GF Score™ of 52/100 and a GF Value™ of $13.87 (Possible Value Trap). The stock has 6 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Lifeward's non-current deferred revenue for the quarter that ended in Mar. 2026 was $1.21 Mil.

Lifeward NonCurrent Deferred Revenue Related Terms

Lifeward NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Lifeward's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifeward NonCurrent Deferred Revenue Chart

Lifeward Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 0.89 1.51 1.32 1.23

Lifeward Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 1.18 1.21 1.23 1.21
LFWD
52GF Score
Lifeward Ltd LFWD
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of $1.21 Mil mean?
Lifeward (LFWD) has a NonCurrent Deferred Revenue of $1.21 Mil as of Mar. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Lifeward and its competitors.
Is Lifeward's NonCurrent Deferred Revenue too high?
Lifeward's current NonCurrent Deferred Revenue is $1.21 Mil. Overall, Lifeward has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lifeward's NonCurrent Deferred Revenue compare to CSDX and CTSO?
Lifeward's NonCurrent Deferred Revenue of $1.21 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Medical Devices & Instruments company?
A good NonCurrent Deferred Revenue depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Lifeward and its competitors. Lifeward's current NonCurrent Deferred Revenue is $1.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifeward stock overvalued right now?
Based on GuruFocus' analysis, Lifeward (LFWD) is currently considered Possible Value Trap. The stock's GF Value™ is $13.87, compared to a current price of $7.45 — trading 46.3% below its estimated fair value. The current NonCurrent Deferred Revenue is $1.21 Mil. Lifeward's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Lifeward (LFWD), the current NonCurrent Deferred Revenue is $1.21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifeward (LFWD) Overvalued in 2026?

Based on GuruFocus' analysis, Lifeward stock appears to be undervalued. The current stock price of $7.45 is trading 46.3% below its estimated GF Value™ of $13.87. GuruFocus considers Lifeward to be Possible Value Trap.

Key valuation signals for LFWD:

  • NonCurrent Deferred Revenue: $1.21 Mil
  • GF Value™: $13.87 vs. price of $7.45 (46.3% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the LFWD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lifeward Business Description

Address 2 Cabot Road, Hudson, MA, USA, 01749
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
52GF Score

Get the complete analysis for LFWD

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.45
Price
$13.87
GF Value